Quantcast

Trump Receiving Remdesivir, Zinc

President Donald Trump arrives at Walter Reed National Military Medical Center, in Bethesda, Md., Friday, Oct. 2, 2020, on Marine One helicopter after he tested positive for COVID-19. (AP Photo/Jacquelyn Martin)

Oct 3, 2020

Washington Post – The president is receiving remdesivir, an antiviral drug that has shown modest benefits for some people, at Walter Reed National Military Medical Center and has “completed his first dose and is resting comfortably,” according to a late Friday statement from his physician.

Remdesivir was developed in partnership with government agencies and at least $70 million from U.S. taxpayers.

For doctors and researchers, clinical studies have reinforced questions about the effectiveness of the drug and who is best suited to receive it.

...article continued below
- Advertisement -

The most conclusive evidence shows it reduces hospital stays from 15 to 11 days but does not significantly reduce the odds of dying of the coronavirus.

Earlier Friday, Trump’s physician said the president had received an “antibody cocktail” and was “fatigued but in good spirits.” That update came shortly before the president was flown to Walter Reed “out of an abundance of caution.”

The “cocktail” administered to Trump is an experimental treatment made by the pharmaceutical company Regeneron and is one of the most promising known. Experts say it could be the best bet for fighting the virus.

“Following PCR-confirmation of the president’s diagnosis, as a precautionary measure he received a single 8 gram dose of Regeneron’s polyclonal antibody cocktail,” White House physician Sean Conley said in a statement.

He said the president completed that treatment “without incident,” and that Trump was also taking zinc, vitamin D, famotidine, melatonin and a daily aspirin.

...article continued below
- Advertisement -

Regeneron manufactures the drug, a cocktail of two monoclonal antibodies, from hamster ovary cells. It’s meant to reduce the virus’s lethality by boosting a patient’s immune defense.

Early data from the drug’s trials are encouraging but preliminary. When it works, it can prevent an illness from progressing to the point where a person may need to be hospitalized or put on a ventilator.

In a statement, Regeneron confirmed that it provided the president with the treatment after his physicians filed a “compassionate use” request, a rare exception to the drug’s use, which at this point is mainly confined to clinical trials.

“In addition to the clinical trial supply and product being manufactured under an agreement with the U.S. government,” the statement read, “there is limited product available for compassionate use requests that have been approved under rare, exceptional circumstances on a case-by-case basis.” Source. 

ALSO ON HEADLINE HEALTH TODAY: Dem. Senate Candidate Won’t Quit Despite Sexting Scandal | Kellyanne | Covid Has Killed 7,000 Animals On Utah Ranches

The president plans to continue his day-to-day duties from Walter Reed

 

- Advertisement -

TRENDING

Wave Of Post-Covid Heart Disease Emerges

EVENING STANDARD (UK) – Up to 300,000 people in the UK are facing heart-related illnesses due to post-pandemic stress disorder (PPSD), two London physicians...

Grand Ole Opry Legend, 89, Dies Of Dementia

NASHVILLE, Tenn. (AP) — Country musician Stonewall Jackson, who sang on the Grand Ole Opry for more than 50 years and had No. 1...

Unvaxxed and Unfriended: Vaccine Views Ruining Relationships

Dear Prudence, My friend “Emma” is not vaccinated against COVID. While I struggle with it, I try not to let it get to me, because...

Omicron Spreads Fast, But No Deaths Reported

SLATE – Omicron continues to spread across the United States, and around the world, as scientists try to pin down how fast it spreads...

Majority of Americans Would Take COVID Pill If They Got Sick

A majority of unvaccinated Americans would decline to take an antiviral medication if they got sick with COVID-19, a new poll found.

Ambassador’s Daughter Beheaded In Islamabad

Islamabad, Pakistan (CNN) – Few cases of femicide make headlines in Pakistan, but the beheading of an ambassador's daughter promises to test a legal...

Omicron “Doubling Daily” In South Africa: WHO

Dec 3 (Reuters) - The World Health Organization's chief scientist told the Reuters Next conference on Friday the Omicron variant could become dominant because...

Biden Mandates Going Nowhere Fast

Associated Press – Millions of health care workers across the U.S. were supposed to have their first dose of a COVID-19 vaccine by this...

New Test Could Reveal Higher Lead Levels In Water

ST. LOUIS (AP) — For years, testing of the tap water in an upscale Detroit suburb showed the city was in the clear. Then...

Vaccinated People With COVID-19 May Be Infectious For A Shorter Period Of Time

Getting the COVID-19 vaccine may not only offer protection against severe complications from the disease. It may also decrease the odds that individuals who get the virus spread it to others — and we’re getting a better idea why.BOSTON.COM – Getting the COVID-19 vaccine may not only offer protection against severe complications from the disease. It may also decrease the odds that individuals who get the virus spread it to others.
- Advertisement -